Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-019893

Options or other derivatives

  • Chief Technical Officer acquired 78,472 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Watler Peter K. · Chief Technical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-05-11 Grant or award : show line 1 in the form Stock Option (Right to Buy) +78,472 78,472 D
Loading xslF345X03/doc4.xml…